Molecular identification and antifungal susceptibility profiles of clinical strains of Fonsecaea spp. isolated from patients with chromoblastomycosis in Rio de Janeiro, Brazil.

• Auteurs principaux: Rowena Alves Coelho (Auteur), Fábio Brito-Santos (Auteur), Maria Helena Galdino Figueiredo-Carvalho (Auteur), Juliana Vitoria Dos Santos Silva (Auteur), Maria Clara Gutierrez-Galhardo (Auteur), Antonio Carlos Francesconi do Valle (Auteur), Rosely Maria Zancopé-Oliveira (Auteur), Luciana Trilles (Auteur), Wieland Meyer (Auteur), Dayvison Francis Saraiva Freitas (Auteur), Rodrigo Almeida-Paes (Auteur)
• Format: Livre
• Publié: Public Library of Science (PLoS), 2018-07-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

BACKGROUND:Chromoblastomycosis (CBM) is a difficult-to-treat chronic subcutaneous mycosis. In Brazil, the main agent of this disease is Fonsecaea pedrosoi, which is phenotypically very similar to other Fonsecaea species, differing only genetically. The correct species identification is relevant sinc...